Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
QDPR encodes the enzyme dihydropteridine reductase, which catalyzes the NADH-mediated reduction of quinonoid dihydrobiopterin. Additionally we are shipping Quinoid Dihydropteridine Reductase Kits (14) and Quinoid Dihydropteridine Reductase Proteins (14) and many more products for this protein.
Showing 10 out of 55 products:
Human Monoclonal QDPR Primary Antibody for RNAi, ELISA - ABIN562551
Ishii, Dutta, Wark, Hwang, Han, Trapp, Pfeiffer, Bansal: Human myelin proteome and comparative analysis with mouse myelin. in Proceedings of the National Academy of Sciences of the United States of America 2009
show for the first time statistically significant up regulation of iNOS in QDPR overexpressing astrocytes. Increased expression of iNOS associated with astrocyte pathology seen in many neurodegenerative disorders may have implications in autoimmune neurodegenerative disorders.
Mutation of dihydropteridine reductase (QDPR) inhibited the regulation of TOR serine-threonine kinases (mTOR), suggesting that QDPR is a positive regulator of autophagy via suppressing mTOR signaling.
The allele frequencies for the QDPR c.68G > A(0.3%) polymorphism is not a major cause of Parkinson's disease in the Maltese.
The mutation spectrum of the QDPR gene is different in the Chinese population. Most mutations are related to severe phenotype.
JP1 and JP2 can facilitate the assembly of DHPR with other proteins of the excitation-contraction coupling machinery
Report suggests that serum prolactin levels can be a good biomarker for optimal dosage of hydroxylated precursors in long-term treatment monitoring for DHPR-deficient patients.
the electrostatic regulatory interaction between the SPRY2 F loop residues (that bind to imperatoxin A) and the ASI/basic residues of RyR1 does not influence bi-directional DHPR-RyR1 signaling during skeletal EC coupling
This protein has been found differentially expressed in thalami from patients with schizophrenia.
less than 30 microM H2O2 increase DHPR activities, whereas levels greater than 30 microM H2O2 deactivate the enzyme based on the oxidation of Met146 and Met151 in the sequence, consequently leading to disruption of the NADH-dependent enzyme active site.
This protein has been found differentially expressed in the Wernicke's Area from patients with schizophrenia.
This gene encodes the enzyme dihydropteridine reductase, which catalyzes the NADH-mediated reduction of quinonoid dihydrobiopterin. This enzyme is an essential component of the pterin-dependent aromatic amino acid hydroxylating systems. Mutations in this gene resulting in QDPR deficiency include aberrant splicing, amino acid substitutions, insertions, or premature terminations. Dihydropteridine reductase deficiency presents as atypical phenylketonuria due to insufficient production of biopterin, a cofactor for phenylalanine hydroxylase.
, dihydropteridine reductase
, short chain dehydrogenase/reductase family 33C, member 1
, quinoid dihydropteridine reductase
, Dihydropteridine reductase
, quinoid dihydropteridine reductase a